Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Oct 03, 2023 9:16pm
220 Views
Post# 35668169

Proof by U.S. Federal Law: We have Pfizer as a customer

Proof by U.S. Federal Law: We have Pfizer as a customer First of all, all pharmaceutical companies in the U.S. have to abide by Federal Law including the FDA.
That would include Arena Pharmaceuticals having to procure their active cannabinoid molecules from an FDA approved source or otherwise all clinical trial data from Arena would be null and void at the FDA since the material did not come from an FDA source.   So one of a pipeline of drugs involved a cannabis drug for bowel disease.   The FDA did not reject Arena's clinical data meaning the only source of those cannabinoid molecules would be Medipharm Labs, the only company approved by the FDA for pharmaceutical cannabinoids.   Since Arena Pharma was bought out by Pfizer then by Federal Law, we have proof that Pfizer is one of our customers as well as Medipharm Labs being the only publicly listed company as well.

Give it a little while longer, sometimes it takes a little bit of time for things to sink in with investors and to connect those dots.   You will know when those dots are connecting fast when you start seeing volumes surging into the millions of shares per day.  


<< Previous
Bullboard Posts
Next >>